Better Way Health Beta Glucan vs Host Defense® Reishi

This Immune System Supplement comparison study was published in the peer-reviewed* medical journal Applied Scientific Reports. The study tested many of the best known products in order to see which ones are the most effective. This study, Comparison of Immunological Effects of Commercially Available β-Glucans consisted of several different assays (i.e., tests) measuring the effectiveness that each product had on varying Immune System Cells.

This particular study was conducted by an immunologist from the University of Louisville named Vaclav Vetvicka, Ph.D. The results below show the comparison data of Host Defense® Reishi compared to Glucan 300® by Better Way Health.

*It is important to note that the peer-review process ensures that the Scientists, PhDs, and MDs facilitating this research have no bias toward specific brands, variations, or the companies involved. Their sole purpose is to analyze the material in question and to discover how these products impact the immune system, rather than what the companies that manufacture them claim they are doing.

	Better Way Health Beta Glucan	Host Defense® Reishi
Packaging:
Brand Logo:
Company Name:	Better Way Health	Host Defense®
Company Location:	Kennesaw, GA	Olympia, WA
Website URL:	https://www.betterwayhealth.com/	https://hostdefense.com/
Primary Ingredient:	Beta 1, 3D Glucan (Glucan 300®)	Reishi (Ganoderma lucidim s.I.)
Additional Ingredients:	Vegetarian Capsules	Mycelium/fermented brown rice biomass, Pullulan (capsule)
Source:	Baker's Yeast	Mushroom
Solubility:	Insoluble	Soluble
Recommended Dosage:	Take two capsules daily. We recommend taking the capsules on an empty stomach, then wait 30 minutes before eating or as directed by a healthcare professional.	As a dietary supplement, take 2 capsules once per day. Can be taken with food or on an empty stomach or as recommended by your healthcare professional.
Total Quantity:	60 Vegi-Caps	60 capsules
Type:	Vegi Caps	Capsules
Number of Scientific Journals Published:	20+	1

Scientific Trial Results

Comparison of Immunological Effects of Commercially Available β-Glucans

2014 • Vaclav Vetvicka, Ph.D.• Department of Pathology, University of Louisville, Louisville, KY, USA

https://www.researchgate.net/publication/269782633_Comparison_of_immunological_effects_of_commercially_available_b-glucans

Neutrophil Percent Phagocytosis 400mcg Dose	55.9%	38.9%
Cellular Secretion of IL-2	983.9	288.8
Antibody Formation	343.9% of Control	189.9%
End Weight of Mammary Carcinoma Tumor	302.4 Milligrams (mg)	N/A
Number of Lung Cancer Metastases	11	N/A
End Weight of Liver in Melanoma Mice	1.22 Grams (g)	N/A
End Weight of Lung in Melanoma Mice	.18 Grams (g)	N/A
End Weight of Spleen in Melanoma Mice	.21 Grams (g)	N/A
End Weight of Primary Tumor in Melanoma Mice	.33 Grams (g)	N/A
Comparison Results	#1 Over All when Tested against 90+ Immune System Products in Peer-Reviewed, Medical Journals	Glucan 300® is 128x More effective than Host Defense® Reishi

Conclusion

Price:	$39.95	$31.95
Accolades or Certifications:	Non-GMO, Gluten Free, 100% Natural, GMP Certified, FDA GRAS Certified	Non-GMO, Certified Organic
Side Effects or Allergens:	No Known Side Effects or Allergens	Caution: If you have a medical condition, are taking medications, or are pregnant or breastfeeding, consult a healthcare professional before using this product. Keep out of reach of children.
Guarantee or Warranty:	60-Day, 100% Money Back Guarantee	At Fungi Perfecti, we take great pride in our Host Defense® products. If for any reason you are not satisfied with your purchase of Host Defense, our goal is to make it right. Please see the terms of our Host Defense 90-Day Satisfaction Guarantee
Shelf Life:	5-Year Shelf Life	Not Disclosed
How Much More Effective?	Glucan 300® by Better Way Health was tested against Host Defense® Reishi. Glucan 300® was found to be 128x More Effective in the 2014 Study titled "Comparison of Immunological Effects of Commercially Available β-Glucans"; the Peer-Reviewed Research is Published in the journal "International Clinical Pathology Journal." Tests were led by Dr. Vaclav Vetvicka, Ph.D. from the University of Louisville.